Skip to main content Accessibility help
×
×
Home

Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure

  • Raymund B. Dantes (a1) (a2), Clare Rock (a3), Aaron M. Milstone (a4), Jesse T. Jacob (a5), Sheri Chernetsky-Tejedor (a1), Anthony D. Harris (a6) and Surbhi Leekha (a6)...

Abstract

Hospital-onset bacteremia and fungemia (HOB), a potential measure of healthcare-associated infections, was evaluated in a pilot study among 60 patients across 3 hospitals. Two-thirds of all HOB events and half of nonskin commensal HOB events were judged as potentially preventable. Follow-up studies are needed to further develop this measure.

Copyright

Corresponding author

Author for correspondence: Raymund B. Dantes, Email: Raymund.dantes@emoryhealthcare.org

References

Hide All
1.Centers for Disease Control and Prevention. National and State Healthcare Associated Infections Progress Report. In: Division of Healthcare Quality Promotion NCEZID. Atlanta, GA: Centers for Disease Control and Prevention; 2016.
2.Healthcare-associated infections in the United States, 2006-2016: a story of progress. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/surveillance/data-reports/data-summary-assessing-progress.html. Published 2018. Accessed July 17, 2018.
3.Leekha, S, Li, S, Thom, KA, et al. Comparison of total hospital-acquired bloodstream infections to central line-associated bloodstream infections and implications for outcome measures in infection control. Infect Control Hosp Epidemiol 2013;34:984986.
4.Rock, C, Thom, KA, Harris, AD, et al. A multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure? Infect Control Hosp Epidemiol 2016;37:143148.
5.Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:27252732.
6.Blijlevens, NM, Donnelly, JP, De Pauw, BE.Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transpl 2000;25:12691278.
7.Linsenmeyer, K, Gupta, K, Strymish, JM, Dhanani, M, Brecher, SM, Breu, AC. Culture if spikes? Indications and yield of blood cultures in hospitalized medical patients. J Hosp Med 2016;11:336340.
8.Alahmadi, YM, Aldeyab, MA, McElnay, JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 2011;77:233236.
9.Waltzman, ML, Harper, M. Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 2001;33:296299.
10.Towns, ML, Jarvis, WR, Hsueh, PR. Guidelines on blood cultures. J Microbiol Immunol Infect 2010;43:347349.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed